<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02300870</url>
  </required_header>
  <id_info>
    <org_study_id>BWHMG370000</org_study_id>
    <nct_id>NCT02300870</nct_id>
  </id_info>
  <brief_title>Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection</brief_title>
  <official_title>Myocardial Perfusion Echocardiography to Detect Human Heart Transplant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>General Electric</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this proposal is to show the efficacy of contrast enhanced
      ultrasonography in detecting heart transplant rejection in humans. The secondary objective is
      to demonstrate the efficacy of this technique in generating data which allow for the
      assessment of short and long term outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Global and regional microvascular myocardial perfusion</measure>
    <time_frame>Baseline</time_frame>
    <description>Myocardial blood flow (dB/s)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Heart Transplantation</condition>
  <arm_group>
    <arm_group_label>Heart Transplant Rejection</arm_group_label>
    <description>Patients presenting with acute cellular rejection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Transplant Control</arm_group_label>
    <description>Patients presenting for routine office visit</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Optison</intervention_name>
    <description>Echocardiogram with IV contrast</description>
    <arm_group_label>Heart Transplant Rejection</arm_group_label>
    <arm_group_label>Heart Transplant Control</arm_group_label>
    <other_name>Echocontrast agent</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Heart Transplant patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult subjects (ages 18 to 75) who have undergone heart transplant at Brigham and
             Women's Hospital

        Exclusion Criteria:

          -  hemodynamic instability (e.g., systolic blood pressure &lt; 90 mmHg)

          -  atrial fibrillation with rapid ventricular response (e.g., heart rate &gt; 120 bpm)

          -  premature atrial or ventricular complexes of a frequency that will not allow adequate
             echocardiographic assessment

          -  poor acoustic windows

          -  inability to provide informed consent

          -  any contraindication listed in the Optison package insert (i.e., history of an
             allergic reaction)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Givertz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Givertz, MD</last_name>
    <phone>617-525-7052</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reza Abdi, MD</last_name>
    <phone>617-732-7249</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael M Givertz, MD</last_name>
      <phone>617-525-7052</phone>
      <email>mgivertz@bwh.harvard.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2014</study_first_submitted>
  <study_first_submitted_qc>November 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2014</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Michael Givertz, MD</investigator_full_name>
    <investigator_title>Medical Director, Heart Transplant and Mechanical Circulatory Support</investigator_title>
  </responsible_party>
  <keyword>Acute rejection, myocardial blood flow</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

